At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FRLN Freeline Therapeutics Holdings plc
Halted 02-16 16:00:00 EST
6.48
+0.00
0.00%
High6.48Low6.48Vol0.00
Open6.48D1 Closing6.48Amplitude0.00%
Mkt Cap28.25MTradable Cap11.58MTotal Shares4.36M
T/O36.65KT/O Rate0.00%Tradable Shares1.79M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
No data available

Introduction

Company Name.
Freeline Therapeutics Holdings plc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
Issue price:
--